Phylogenetic analysis of the promoter region of the CD40L gene in primates and other mammals

Infection, Genetics and Evolution

Volumn 8, Issue 4, 2008, Pages 406-413

  Steiper, Michael E ^a,b   Parikh, Sonia J ^a   Zichello, Julia M ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

CD154; Evolution; Gene regulation; Hyper IgM; Immune system; NF AT; Phylogenetic shadowing; XHIGM; XHIM

Indexed keywords

CD40 LIGAND; TRANSCRIPTION FACTOR NFAT;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA SEQUENCE; GENETIC CONSERVATION; GENETIC REGULATION; MAMMAL; MOLECULAR EVOLUTION; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIMATE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE;

ANIMALS; BASE SEQUENCE; CD40 LIGAND; HUMANS; MAMMALS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PRIMATES; PROMOTER REGIONS (GENETICS); SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID;

MAMMALIA; PRIMATES;

EID: 43649107547     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2006.12.004     Document Type: Article

References (41)

1. Allen R.C., Armitage R.J., Conley M.E., Rosenblatt H., Jenkins N.A., Copeland N.G., Bedell M.A., Edelhoff S., Disteche C.M., Simoneaux D.K., et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259 (1993) 990-993
2. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L.S., Stenkamp R., Neubauer M., et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72 (1993) 291-300
3. Boffelli D., McAuliffe J., Ovcharenko D., Lewis K.D., Ovcharenko I., Pachter L., and Rubin E.M. Phylogenetic shadowing of primate sequences to find functional regions of the human genome. Science 299 (2003) 1391-1394
4. Carroll S.B. Evolution at two levels: on genes and form. PLoS Biol. 3 (2005) e245
5. Cron R.Q., Bandyopadhyay R., Genin A., Brunner M., Kersh G.J., Yin J., Finkel T.H., and Crow M.K. Early growth response-1 is required for CD154 transcription. J. Immunol. 176 (2006) 811-818
6. DiSanto J.P., Bonnefoy J.Y., Gauchat J.F., Fischer A., and de Saint Basile G. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 541-543
7. Etzioni A., and Ochs H.D. The hyper IgM syndrome-an evolving story. Pediatr. Res. 56 (2004) 519-525
8. Fuleihan R., Ramesh N., Loh R., Jabara H., Rosen R.S., Chatila T., Fu S.M., Stamenkovic I., and Geha R.S. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2170-2173
9. Gauchat J.F., Aubry J.P., Mazzei G., Life P., Jomotte T., Elson G., and Bonnefoy J.Y. Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production. FEBS Lett. 315 (1993) 259-266
10. Goodman M., Porter C.A., Czelusniak J., Page S.L., Schneider H., Shoshani J., Gunnell G., and Groves C.P. Toward a phylogenetic classification of primates based on DNA evidence complemented by fossil evidence. Mol. Phylogenet. Evol. 9 (1998) 585-598
11. Gumucio D.L., Heilstedt-Williamson H., Gray T.A., Tarle S.A., Shelton D.A., Tagle D.A., Slightom J.L., Goodman M., and Collins F.S. Phylogenetic footprinting reveals a nuclear protein which binds to silencer sequences in the human gamma and epsilon globin genes. Mol. Cell. Biol. 12 (1992) 4919-4929
12. Gumucio D.L., Shelton D.A., Bailey W.J., Slightom J.L., and Goodman M. Phylogenetic footprinting reveals unexpected complexity in trans factor binding upstream from the epsilon-globin gene. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6018-6022
13. Hollenbaugh D., Grosmaire L.S., Kullas C.D., Chalupny N.J., Braesch-Andersen S., Noelle R.J., Stamenkovic I., Ledbetter J.A., and Aruffo A. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11 (1992) 4313-4321
14. Howard L.M., and Miller S.D. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease. Autoimmunity 37 (2004) 411-418
15. Huan C., Kelly M.L., Steele R., Shapira I., Gottesman S.R., and Roman C.A. Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity. Nat. Immunol. 7 (2006) 1082-1091
16. King M.C., and Wilson A.C. Evolution at two levels in humans and chimpanzees. Science 188 (1975) 107-116
17. Korthauer U., Graf D., Mages H.W., Briere F., Padayachee M., Malcolm S., Ugazio A.G., Notarangelo L.D., Levinsky R.J., and Kroczek R.A. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361 (1993) 539-541
18. Levy J., Espanol-Boren T., Thomas C., Fischer A., Tovo P., Bordigoni P., Resnick I., Fasth A., Baer M., Gomez L., Sanders E.A., Tabone M.D., Plantaz D., Etzioni A., Monafo V., Abinun M., Hammarstrom L., Abrahamsen T., Jones A., Finn A., Klemola T., DeVries E., Sanal O., Peitsch M.C., and Notarangelo L.D. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr. 131 (1997) 47-54
19. Lindgren H., Axcrona K., and Leanderson T. Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2. J. Immunol. 166 (2001) 4578-4585
20. Lobo F.M., Xu S., Lee C., and Fuleihan R.L. Transcriptional activity of the distal CD40 ligand promoter. Biochem. Biophys. Res. Commun. 279 (2000) 245-250
21. Loots G.G., and Ovcharenko I. Dcode.org anthology of comparative genomic tools. Nucleic Acids Res. 33 (2005) W56-W64
22. Lopez-Granados E., Cambronero R., Ferreira A., Fontan G., and Garcia-Rodriguez M.C. Three novel mutations reflect the variety of defects causing phenotypically diverse X-linked hyper-IgM syndrome. Clin. Exp. Immunol. 133 (2003) 123-131
23. Murphy W.J., Pevzner P.A., and O'Brien S.J. Mammalian phylogenomics comes of age. Trends Genet. 20 (2004) 631-639
24. Opazo J.C., Wildman D.E., Prychitko T., Johnson R.M., and Goodman M. Phylogenetic relationships and divergence times among New World monkeys (Platyrrhini primates). Mol. Phylogenet. Evol. 40 (2006) 274-280
25. Ovcharenko I., Boffelli D., and Loots G.G. eShadow: a tool for comparing closely related sequences. Genome Res. 14 (2004) 1191-1198
26. Padayachee M., Feighery C., Finn A., McKeown C., Levinsky R.J., Kinnon C., and Malcolm S. Mapping of the X-linked form of hyper-IgM syndrome (HIGM1) to Xq26 by close linkage to HPRT. Genomics 14 (1992) 551-553
27. Parra E., Mustelin T., Dohlsten M., and Mercola D. Identification of a CD28 response element in the CD40 ligand promoter. J. Immunol. 166 (2001) 2437-2443
28. Perry G.H., Verrelli B.C., and Stone A.C. Molecular evolution of the primate developmental genes MSX1 and PAX9. Mol. Biol. Evol. 23 (2006) 644-654
29. Piguet P.F., Kan C.D., Vesin C., Rochat A., Donati Y., and Barazzone C. Role of CD40-CD40L in mouse severe malaria. Am. J. Pathol. 159 (2001) 733-742
30. Posada D., and Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 14 (1998) 817-818
31. Sabeti P., Usen S., Farhadian S., Jallow M., Doherty T., Newport M., Pinder M., Ward R., and Kwiatkowski D. CD40L association with protection from severe malaria. Genes Immun. 3 (2002) 286-291
32. Sabeti P.C., Reich D.E., Higgins J.M., Levine H.Z., Richter D.J., Schaffner S.F., Gabriel S.B., Platko J.V., Patterson N.J., McDonald G.J., Ackerman H.C., Campbell S.J., Altshuler D., Cooper R., Kwiatkowski D., Ward R., and Lander E.S. Detecting recent positive selection in the human genome from haplotype structure. Nature 419 (2002) 832-837
33. Schubert L.A., King G., Cron R.Q., Lewis D.B., Aruffo A., and Hollenbaugh D. The human gp39 promoter. Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation. J. Biol. Chem. 270 (1995) 29624-29627
34. Siddiqa A., Sims-Mourtada J.C., Guzman-Rojas L., Rangel R., Guret C., Madrid-Marina V., Sun Y., and Martinez-Valdez H. Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA. Nature 410 (2001) 383-387
35. Srahna M., Remacle J.E., Annamalai K., Pype S., Huylebroeck D., Boogaerts M.A., and Vandenberghe P. NF-kappaB is involved in the regulation of CD154 (CD40 ligand) expression in primary human T cells. Clin. Exp. Immunol. 125 (2001) 229-236
36. * and Other Methods). Version 4. Sinauer Associates, Sunderland, MA.
37. Tagle D.A., Koop B.F., Goodman M., Slightom J.L., Hess D.L., and Jones R.T. Embryonic epsilon and gamma globin genes of a prosimian primate (Galago crassicaudatus). Nucleotide and amino acid sequences, developmental regulation and phylogenetic footprints. J. Mol. Biol. 203 (1988) 439-455
38. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25 (1997) 4876-4882
39. Tsytsykova A.V., Tsitsikov E.N., and Geha R.S. The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J. Biol. Chem. 271 (1996) 3763-3770
40. Vihinen, M., 2006. CD40Lbase v.2.04.
41. Villa A., Notarangelo L.D., Di Santo J.P., Macchi P.P., Strina D., Frattini A., Lucchini F., Patrosso C.M., Giliani S., Mantuano E., et al. Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2110-2114